British National Lymphoma Investigation: Pilot Studies of Neoadjuvant Chemotherapy in Clinical Stage Ia and IIa Hodgkin's Disease

Coronary artery disease mortality in patients treated for hodgkin's disease

Jean‐François Boivin, George B. Hutchison, Jay H. Lubin et al. · Cancer · 1992 · 285 citations

Medicine, Oncology, Radiation Oncology +8

Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation.

Anthony J. Swerdlow, A. J. Douglas, G. Vaughan Hudson et al. · BMJ · 1992 · 244 citations · Full text

Medicine, Oncology, Pathology +15

REVIEW OF BRITISH NATIONAL LYMPHOMA INVESTIGATION STUDIES OF HODGKIN'S DISEASE AND DEVELOPMENT OF PROGNOSTIC INDEX

J. L. Haybittle, M.J. Easterling, MR Bennett et al. · The Lancet · 1985 · 183 citations

Medicine, Oncology, Pathology +7

Vinblastine, bleomycin, and methotrexate: an effective adjuvant in favorable Hodgkin's disease.

Sandra J. Horning, R T Hoppe, S.L. Hancock et al. · Journal of Clinical Oncology · 1988 · 130 citations

Medicine, Oncology, Radiation Oncology +14

Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital

Alan Horwich, David Cunningham · British Journal of Cancer · 1997 · 84 citations · Full text

Medicine, Oncology, Surgery +10